Updated 11/26/2024
On November 15, 2024, the Drug Enforcement Administration (DEA) and Department of Health and Human Services (HHS) announced the extension of flexibilities around telemedicine prescribing of controlled substances until December 31, 2025.
January 1, 2025
- Telemedicine flexibilities allowing prescribing of schedule II-V controlled substances via telemedicine without an in-person evaluation.
- Bill telehealth visits using same CPT codes as in person visits with addition of modifiers to identify telehealth visits.
- Allow the use of live video to meet direct supervision requirements.
- Distant site practitioner can use currently enrolled practice location instead of home address when providing telehealth services.
- Three new digital mental health treatment (DMHT) devices codes.
- GBMT1-3, pay for the supply of a digital mental health treatment device and for physician time spent interacting with the patient regarding the device.
- Returning to Medicare 6-month in-person prior to a telehealth visit requirement.
Permanent
- Audio-only provision of mental health services in Medicare
- The patient’s home as an acceptable originating site in Medicare
- Virtual supervision of some “incident to” services